Evidence map›Paper›PMID 29719832›Full record

ArticleFrontiers in cell and developmental biology2018

Microenvironment-Induced Non-sporadic Expression of the AXL and cKIT Receptors Are Related to Epithelial Plasticity and Drug Resistance.

Tiina A Jokela, Agnete S T Engelsen, Agata Rybicka, Fanny A Pelissier Vatter, James C Garbe, Masaru Miyano, Crina Tiron, Dan Ferariu, Lars A Akslen, Martha R Stampfer and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Navigating TAM receptor dynamics in tumour immunotherapy.Cancer immunology, immunotherapy : CII · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. High-Throughput Microenvironment Microarray (MEMA) High-Resolution Imaging.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Tiina A JokelaDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Agnete S T EngelsenDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Agata RybickaDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Fanny A Pelissier VatterDepartment of Biomedicine, University of Bergen, Bergen, Norway.
James C GarbeBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, United States.
Masaru MiyanoDepartment of Population Sciences, Center for Cancer and Aging, City of Hope, Duarte, CA, United States.
Crina TironRegional Institute of Oncology, Iasi, Romania.
Dan FerariuRegional Institute of Oncology, Iasi, Romania.
Lars A AkslenCentre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
Martha R StampferBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, United States.
James B LorensDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Mark A LaBargeDepartment of Population Sciences, Center for Cancer and Aging, City of Hope, Duarte, CA, United States.
University of Bergen · NOLawrence Berkeley National Laboratory · USCity of Hope · USInstitutul Regional de Oncologie · RO

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
OutreachU54HG008100 · NHGRI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GRAY, JOE W., GRAY, JOE W. · 2014 to 2019
$10.5M
Age-related shifts in epithelial lineages and tissue homeostasis in mammary gland 5R01AG040081-05R01AG040081 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI LABARGE, MARK A · 2011 to 2015
$2.3M
NCI NIH HHS P30 CA033572NHGRI NIH HHS U54 HG008100NIA NIH HHS R01 AG040081
6 · The paper itself

Abstract

The existence of rare cancer cells that sporadically acquire drug-tolerance through epigenetic mechanisms is proposed as one mechanism that drives cancer therapy failure. Here we provide evidence that specific microenvironments impose non-sporadic expression of proteins related to epithelial plasticity and drug resistance. Microarrays of robotically printed combinatorial microenvironments of known composition were used to make cell-based functional associations between microenvironments, which were design-inspired by normal and tumor-burdened breast tissues, and cell phenotypes. We hypothesized that specific combinations of microenvironment constituents non-sporadically impose the induction of the AXL and cKIT receptor tyrosine kinase proteins, which are known to be involved in epithelial plasticity and drug-tolerance, in an isogenic human mammary epithelial cell (HMEC) malignant progression series. Dimension reduction analysis reveals type I collagen as a dominant feature, inducing expression of both markers in pre-stasis finite lifespan HMECs, and transformed non-malignant and malignant immortal cell lines. Basement membrane-associated matrix proteins, laminin-111 and type IV collagen, suppress AXL and cKIT expression in pre-stasis and non-malignant cells. However, AXL and cKIT are not suppressed by laminin-111 in malignant cells. General linear models identified key factors, osteopontin, IL-8, and type VIα3 collagen, which significantly upregulated AXL and cKIT, as well as a plasticity-related gene expression program that is often observed in stem cells and in epithelial-to-mesenchymal-transition. These factors are co-located with AXL-expressing cells

Indexed as

AXLbreast cancercKITdrug resistanceepithelial plasticityMEMAmicroenvironment

Identifiers

PMID29719832
PMCPMC5913284
OpenAlexW2799904540

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.